• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

In vitroexpansion or induction of regulatory T cells from olcerative colitis patients

Research Project

Project/Area Number 18590685
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKyushu University

Principal Investigator

NAKAMURA Kazuhiko  Kyushu University, Graduate School of Medical Sciences, Assistant Professor (00274449)

Co-Investigator(Kenkyū-buntansha) AKIHO Hirotada  Kyushu University, Hospital, Assistant Professor (10380411)
Project Period (FY) 2006 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥3,890,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥390,000)
Fiscal Year 2007: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2006: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsinflammatory bowel disease / regulatory T cell / immunology
Research Abstract

CD4^+CD25^+ regulatory T cells (Treg) possess broad range of immunoregulatory activity which regulates autoimmune disorders including inflammatory bowel diseases in animal models. Aiming the clinical application of Treg for the treatment of ulcerative colitis (UC), we investigated whether Treg can be expanded or induced in vitro. We stimulated Tregs isolated from the leukapheresis products from UC patients with anti-CD3/anti-CD28-bearing beads and IL-2. Treg could be increased 18 times in 10 days culture. Cultured Treg maintained the expression of a Treg-specific marker, FOXP3 and significantly suppressed the CD4^+ T cell-proliferation upon coculture. Thus, Treg can be expanded in vitro.
Next, we tested whether Treg can be induced in vitro CD4^+CD255non-Treg were stimulated and cultured in the presence of TGF-β1. Cultured cells expressed FOXP3 and suppressed the CD4^+ T cell-proliferation upon coculture. Therefore, Treg can be even induced from non-Treg in vitro.
Then, we investigate whether induced Treg are able to suppress intestinal inflammation. We induced Treg from CD4^+ T cells stimulating with anti-CD3/anti-CD28 and IL-2 in the presence of rapamycin (RAPA). When CD4^+ T cells were stimulated in the presence of RAPA, 17% was CD25^+FoxP3^+ at the end of 21-day culture. In contrast, few cells stimulated without RAPA expressed CD25 and FoxP3. CB-17 Scid mice were transferred with CD4^+CD62L^+CD25^-T cells, which developed chronic persistent colitis. Co-transfer of CD4^+ T cells stimulated in the presence of RAPA suppressed colitis as naturally-occurring Treg, while CD4^+ T cells cultured in the absence of RAPA failed to ameliorate intestinal inflammation. Therefore, RAPA induced Treg, which are capable of suppressing colitis.
These results indicate that Treg can be expanded or induced in vitro and transfer of induced Treg may be efficacious for the treatment of inflammatory bowel diseases.

Report

(3 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report
  • Research Products

    (9 results)

All 2008 2007 2006

All Journal Article (7 results) (of which Peer Reviewed: 3 results) Presentation (2 results)

  • [Journal Article] A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice2008

    • Author(s)
      Sun, et. al.
    • Journal Title

      Gastroenterology 134

      Pages: 447-458

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice2008

    • Author(s)
      Sun, X., Somada, S., Shibata, K., Muta, H., Yamada, H., Yoshihara, H., Honda, K., Nakamura, K., Takayanagi, R., Tani, K., Podack, ER., Yoshikai, Y
    • Journal Title

      Gastroenterology 134

      Pages: 447-458

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice2008

    • Author(s)
      Sun X, et. al.
    • Journal Title

      Gastroenterology 134

      Pages: 447-458

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] An inverse correlation of human peripheral blood regulatory T cell frequency with the disease actlvity of ulcerative colitis2006

    • Author(s)
      Takahashi, et. al.
    • Journal Title

      Digestive Diseases and Sciences 51

      Pages: 677-686

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis2006

    • Author(s)
      Takahashi, M., Nakamura, K., Honda, K., Kitamura, Y., Mizutani, T., Araki, Y., Kabemura, T., Chijiiwa, Y., Harada, N., Nawata, H
    • Journal Title

      Dig Dis Sci 51

      Pages: 677-686

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis.2006

    • Author(s)
      Takahashi et al.
    • Journal Title

      Digestive Diseases and Sciences 51

      Pages: 677-686

    • Related Report
      2006 Annual Research Report
  • [Journal Article] 制御性T細胞をどう治療に生かすか?2006

    • Author(s)
      中村和彦
    • Journal Title

      炎症と免疫 14

      Pages: 86-92

    • Related Report
      2006 Annual Research Report
  • [Presentation] 潰瘍性大腸炎に対する血球成分除去制御性T細胞分離・移入療法の開発:無菌的細胞分離法の確立2007

    • Author(s)
      隅田 頼信, 他
    • Organizer
      第49回日本消化器病学会大会
    • Place of Presentation
      神戸
    • Year and Date
      2007-10-19
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Annual Research Report 2007 Final Research Report Summary
  • [Presentation] The development of leukapheresis/regulatory T cell transfer therapy for the treatment of ulcerative colitis : the establishment of aseptic cell isolation protocol2007

    • Author(s)
      Sumida, Y., Nakamura, K., Kanayama, K., Takahashi, M., Mizutani, T., Honda, K., Higuchi, N., Ogino, H., Murao, H., Taki, K., Itaba, S., Akiho, H., Takayanagi, R
    • Organizer
      JDDW2007
    • Place of Presentation
      Kobe
    • Year and Date
      2007-10-19
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary

URL: 

Published: 2006-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi